Abstract
Nanoparticles have emerged as a promising tool for targeted therapy in the field of medicine, offering precise drug delivery systems that can enhance therapeutic efficacy while minimizing side effects. The ability of nanoparticles to selectively target diseased cells or tissues has opened new avenues for the treatment of various conditions, including cancer, neurological disorders, and infections. This paper explores the role of nanoparticles in targeted drug delivery, focusing on their types, mechanisms of action, and clinical applications. Key challenges such as biocompatibility, drug release kinetics, and overcoming biological barriers are also discussed. The future of nanoparticle-based therapies holds great promise for revolutionizing personalized medicine, with ongoing research aimed at improving their design and functionality.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2020 Dr. John Smith (Author)